Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03034213 · ClinicalTrials.gov registry record · NA
Gentrix™ Versus Biological or Prosthetic Mesh
A NA study, sponsored by University of South Florida.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03034213: Clinical Trial NA study, sponsored by University of South Florida.
NCT03034213 is a NA study that was terminated before completion, run by University of South Florida. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03034213, a NA study, was terminated before completion, sponsored by University of South Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The hypothesis for this study is complex incisional hernia repair using the separation of components technique reinforced with retrorectus placement of Gentrix™ Surgical Matrix will lead to fewer incisional hernia recurrences and fewer wound complications compared to the same incisional hernia repair techniques reinforced with other prosthetic or biologically-derived mesh.
Interventions
- DEVICE Gentrix™ Surgical Matrix (Treatment)
- DEVICE Permacol, Parietex, Progrip, Strattice Perforated, or Surgimend (Control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2017-10-06 |
| Est. Completion | 2021-06-16 |
| Phase | NA |
Why NCT03034213 stopped before completion
NCT03034213 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Gentrix™ Surgical Matrix (Treatment) is the first listed.
NCT03034213 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03034213 about?
NCT03034213 is a clinical study titled "Gentrix™ Versus Biological or Prosthetic Mesh". The hypothesis for this study is complex incisional hernia repair using the separation of components technique reinforced with retrorectus placement of Gentrix™ Surgical Matrix will lead to fewer incisional hernia recurrences and fewer wound complications compared to the same incisional hernia repai...
What is the current status of trial NCT03034213?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2017-10-06. Estimated completion is 2021-06-16.
What interventions are being tested in trial NCT03034213?
The interventions under investigation include: Gentrix™ Surgical Matrix (Treatment) (DEVICE), Permacol, Parietex, Progrip, Strattice Perforated, or Surgimend (Control) (DEVICE).
Who is sponsoring clinical trial NCT03034213?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03034213's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI